Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 1
1948 1
1950 9
1951 6
1952 7
1953 4
1954 5
1955 2
1956 2
1957 2
1958 6
1959 3
1960 3
1961 6
1962 6
1963 11
1964 8
1965 8
1966 7
1967 3
1968 9
1969 11
1970 10
1971 11
1972 14
1973 14
1974 11
1975 4
1976 18
1977 11
1978 14
1979 16
1980 16
1981 12
1982 14
1983 18
1984 8
1985 20
1986 22
1987 16
1988 27
1989 25
1990 27
1991 37
1992 19
1993 17
1994 35
1995 40
1996 40
1997 42
1998 50
1999 42
2000 52
2001 53
2002 42
2003 59
2004 66
2005 97
2006 101
2007 123
2008 122
2009 158
2010 196
2011 212
2012 290
2013 327
2014 347
2015 393
2016 415
2017 457
2018 485
2019 520
2020 659
2021 753
2022 890
2023 845
2024 935
2025 522

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,844 results

Results by year

Filters applied: . Clear all
Page 1
Knowledge-Reinforced Cross-Domain Recommendation.
Huang L, Huang XD, Zou H, Gao Y, Wang CD, Yu PS. Huang L, et al. Among authors: yu ps. IEEE Trans Neural Netw Learn Syst. 2024 Nov 28;PP. doi: 10.1109/TNNLS.2024.3500096. Online ahead of print. IEEE Trans Neural Netw Learn Syst. 2024. PMID: 40030341
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial.
Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, Yu J, Bu Z, Chen L, Du Y, Wang X, Wu A, Li G, Su X, Xiao G, Cui M, Wu D, Chen L, Wu X, Zhou Y, Zhang L, Dang C, He Y, Zhang Z, Sun Y, Li Y, Chen H, Bai Y, Wang Y, Yu P, Zhu G, Suo J, Jia B, Li L, Huang C, Li F, Ye Y, Xu H, Wang X, Yuan Y, E J, Ying X, Yao C, Shen L, Ji J. Zhang X, et al. Among authors: yu p. Lancet Oncol. 2025 Mar;26(3):312-319. doi: 10.1016/S1470-2045(24)00676-4. Epub 2025 Feb 11. Lancet Oncol. 2025. PMID: 39952264 Clinical Trial.
The impact of high-IgE levels on metabolome and microbiome in experimental allergic enteritis.
Zubeldia-Varela E, Blanco-Pérez F, Barker-Tejeda TC, Rojo D, Villaseñor A, Islam J, Gonzalez-Menendez I, Laiño J, Krause M, Steigerwald H, Martella M, Quintanilla-Martinez L, Yu P, Barbas C, Vieths S, Nochi T, Barber D, Toda M, Pérez-Gordo M. Zubeldia-Varela E, et al. Among authors: yu p. Allergy. 2024 Dec;79(12):3430-3447. doi: 10.1111/all.16202. Epub 2024 Jun 23. Allergy. 2024. PMID: 38932655 Free PMC article.
8,844 results